XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Oct. 31, 2023 10,343,223      
Balance at Oct. 31, 2023 $ 104 $ 26,087 $ 13,571 $ 39,762
Stock-based compensation expense   255   255
Issuance of restricted stock (in shares) 152,325      
Issuance of restricted stock $ 1      
Issuance of restricted stock   1    
Consolidated net loss     (1,362) (1,362)
Issuance of restricted stock   (1)    
Balance (in shares) at Jan. 31, 2024 10,495,548      
Balance at Jan. 31, 2024 $ 105 26,341 12,209 38,655
Balance (in shares) at Oct. 31, 2024 10,544,431      
Balance at Oct. 31, 2024 $ 106 26,988 6,972 $ 34,066
Exercise of stock options (in shares) 50,623     50,623
Exercise of stock options $ 0 206   $ 206
Stock-based compensation expense   195   195
Issuance of restricted stock (in shares) 82,500      
Issuance of restricted stock $ 1     0
Issuance of restricted stock   (1)    
Tax withholding related to vesting of restricted stock (in shares) (7,677)      
Tax withholding related to vesting of restricted stock   (29)   (29)
Consolidated net loss     (245) (245)
Issuance of restricted stock   1    
Balance (in shares) at Jan. 31, 2025 10,669,877      
Balance at Jan. 31, 2025 $ 107 $ 27,359 $ 6,727 $ 34,193